Ainos, Inc. (AIMD)
NASDAQ: AIMD · IEX Real-Time Price · USD
0.720
-0.030 (-4.00%)
Jul 22, 2024, 10:13 AM EDT - Market open
Ainos Employees
Ainos had 46 employees as of December 31, 2023. The number of employees increased by 3 or 6.98% compared to the previous year.
Employees
46
Change (1Y)
3
Growth (1Y)
6.98%
Revenue / Employee
n/a
Profits / Employee
-$316,628
Market Cap
5.52M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
PolyPid | 62 |
Biomerica | 62 |
Hepion Pharmaceuticals | 22 |
TFF Pharmaceuticals | 19 |
FSD Pharma | 17 |
Aethlon Medical | 14 |
Sonoma Pharmaceuticals | 10 |
Oragenics | 5 |
AIMD News
- 5 weeks ago - Ainos Unveils Critical Progress in Ainos Flora Clinical Trials and Next-Gen Plans Powered by NVIDIA CUDA - Accesswire
- 2 months ago - Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market - Accesswire
- 2 months ago - Ainos Reports First Quarter 2024 Financial Results - Accesswire
- 2 months ago - Ainos Raises $9 Million in Growth Capital with Existing Shareholder - Accesswire
- 4 months ago - Ainos Reports Full Year 2023 Financial Results - Accesswire
- 6 months ago - Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms - Accesswire
- 6 months ago - Ainos Announces $1.75 Million Follow-On Funding - Accesswire
- 7 months ago - Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement - Accesswire